serdexmethylphenidate
Selected indexed studies
- Evaluating serdexmethylphenidate and dexmethylphenidate capsules as a once-daily treatment option for ADHD. (Expert Opin Pharmacother, 2023) [PMID:37226489]
- Azstarys (serdexmethylphenidate/dexmethylphenidate) for ADHD. (Med Lett Drugs Ther, 2021) [PMID:34550957]
- Serdexmethylphenidate/dexmethylphenidate effects on sleep in children with attention-deficit/hyperactivity disorder. (Front Psychiatry, 2023) [PMID:37426086]
_Worker-drafted node — pending editorial review._
Connections
serdexmethylphenidate is a side effect of
Sources
- Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials. (2022) pubmed
- Evaluating serdexmethylphenidate and dexmethylphenidate capsules as a once-daily treatment option for ADHD. (2023) pubmed
- Azstarys (serdexmethylphenidate/dexmethylphenidate) for ADHD. (2021) pubmed
- Pediatric attention deficit hyperactivity disorder (ADHD): 2022 updates on pharmacological management. (2023) pubmed
- Serdexmethylphenidate/dexmethylphenidate effects on sleep in children with attention-deficit/hyperactivity disorder. (2023) pubmed
- Serdexmethylphenidate/dexmethylphenidate for children with attention-deficit/hyperactivity disorder: dose optimization from a laboratory classroom study. (2024) pubmed
- Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study. (2023) pubmed
- Drugs for ADHD. (2025) pubmed
- Pilot Trial of SDX/d-MPH Adult ADHD Examining Effects Throughout the Day. (2025) pubmed
- Oral, intranasal, and intravenous abuse potential of serdexmethylphenidate, a novel prodrug of d-methylphenidate. (2022) pubmed